Scopolamine Hydrobromide Injection (2016-01-22)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type III
| Lot or serial number | Brand name | Companies | Dosage form | DIN, NPN, DIN-HIM | Strength |
|---|
| 290628E01 | Scopolamine Hydrobromide Injection | - Recalling Firm
- Hospira Healthcare Corporation, a Pfizer Company
- 2600 Alfred-Nobel Blvd. Suite 500
- Saint-Laurent
- H4S 0A9
- Quebec
- CANADA
- Marketing Authorization Holder
- Hospira Healthcare Corporation, a Pfizer Company
- 2600 Alfred-Nobel Blvd. Suite 500
- Saint-Laurent
- H4S 0A9
- Quebec
- CANADA
| Sterile solution for injection | DIN 00541869 | 0.4 mg/ml |
Affected products
Scopolamine Hydrobromide Injection
Out of specification result for potency during shelf life testing.
Wholesalers and hospitals across Canada